CNSP logo

CNS Pharmaceuticals (CNSP) EBIT

Annual EBIT

-$18.84 M
-$3.57 M-23.39%

31 December 2023

CNSP EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly EBIT

-$5.60 M
-$3.08 M-121.81%

30 September 2024

CNSP Quarterly EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM EBIT

-$17.04 M
-$1.08 M-6.78%

30 September 2024

CNSP TTM EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CNSP EBIT Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-23.4%-23.9%+8.4%
3 y3 years-99.2%-47.0%-19.7%
5 y5 years-156.5%-701.6%-115.0%

CNSP EBIT High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-99.2%at low-121.8%at low-27.3%+9.5%
5 y5 years-391.4%at low-701.6%at low-344.6%+9.5%
alltimeall time-391.4%at low-3198.2%+15.3%-6686.3%+9.5%

CNS Pharmaceuticals EBIT History

DateAnnualQuarterlyTTM
Sept 2024
-
-$5.60 M(+121.8%)
-$17.04 M(+6.8%)
June 2024
-
-$2.53 M(-28.6%)
-$15.96 M(-8.5%)
Mar 2024
-
-$3.54 M(-34.1%)
-$17.45 M(-7.4%)
Dec 2023
-$18.84 M(+23.4%)
-$5.37 M(+18.8%)
-$18.84 M(+1.3%)
Sept 2023
-
-$4.52 M(+12.5%)
-$18.60 M(+6.3%)
June 2023
-
-$4.02 M(-18.4%)
-$17.50 M(+2.7%)
Mar 2023
-
-$4.93 M(-4.1%)
-$17.04 M(+11.6%)
Dec 2022
-$15.27 M(+5.4%)
-$5.13 M(+50.2%)
-$15.27 M(+14.1%)
Sept 2022
-
-$3.42 M(-4.1%)
-$13.38 M(-2.9%)
June 2022
-
-$3.56 M(+13.2%)
-$13.78 M(-1.8%)
Mar 2022
-
-$3.15 M(-3.1%)
-$14.03 M(-3.2%)
Dec 2021
-$14.49 M
-$3.25 M(-14.7%)
-$14.49 M(+1.8%)
Sept 2021
-
-$3.81 M(+0.1%)
-$14.24 M(+14.5%)
DateAnnualQuarterlyTTM
June 2021
-
-$3.81 M(+5.6%)
-$12.43 M(+12.1%)
Mar 2021
-
-$3.61 M(+20.3%)
-$11.10 M(+17.4%)
Dec 2020
-$9.45 M(+146.7%)
-$3.00 M(+49.3%)
-$9.45 M(+5.3%)
Sept 2020
-
-$2.01 M(-18.7%)
-$8.98 M(+17.1%)
June 2020
-
-$2.47 M(+25.7%)
-$7.66 M(+36.7%)
Mar 2020
-
-$1.97 M(-22.0%)
-$5.61 M(+46.3%)
Dec 2019
-$3.83 M(-47.8%)
-$2.52 M(+261.0%)
-$3.83 M(-51.6%)
Sept 2019
-
-$699.10 K(+68.4%)
-$7.93 M(+7.2%)
June 2019
-
-$415.10 K(+112.8%)
-$7.40 M(+2.3%)
Mar 2019
-
-$195.10 K(-97.1%)
-$7.23 M(+2.8%)
Dec 2018
-$7.35 M
-$6.62 M(+3794.9%)
-$7.04 M(+1571.9%)
Sept 2018
-
-$169.90 K(-32.3%)
-$421.00 K(+67.7%)
June 2018
-
-$251.10 K
-$251.10 K

FAQ

  • What is CNS Pharmaceuticals annual earnings before interest & taxes?
  • What is the all time high annual EBIT for CNS Pharmaceuticals?
  • What is CNS Pharmaceuticals annual EBIT year-on-year change?
  • What is CNS Pharmaceuticals quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for CNS Pharmaceuticals?
  • What is CNS Pharmaceuticals quarterly EBIT year-on-year change?
  • What is CNS Pharmaceuticals TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for CNS Pharmaceuticals?
  • What is CNS Pharmaceuticals TTM EBIT year-on-year change?

What is CNS Pharmaceuticals annual earnings before interest & taxes?

The current annual EBIT of CNSP is -$18.84 M

What is the all time high annual EBIT for CNS Pharmaceuticals?

CNS Pharmaceuticals all-time high annual earnings before interest & taxes is -$3.83 M

What is CNS Pharmaceuticals annual EBIT year-on-year change?

Over the past year, CNSP annual earnings before interest & taxes has changed by -$3.57 M (-23.39%)

What is CNS Pharmaceuticals quarterly earnings before interest & taxes?

The current quarterly EBIT of CNSP is -$5.60 M

What is the all time high quarterly EBIT for CNS Pharmaceuticals?

CNS Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$169.90 K

What is CNS Pharmaceuticals quarterly EBIT year-on-year change?

Over the past year, CNSP quarterly earnings before interest & taxes has changed by -$1.08 M (-23.95%)

What is CNS Pharmaceuticals TTM earnings before interest & taxes?

The current TTM EBIT of CNSP is -$17.04 M

What is the all time high TTM EBIT for CNS Pharmaceuticals?

CNS Pharmaceuticals all-time high TTM earnings before interest & taxes is -$251.10 K

What is CNS Pharmaceuticals TTM EBIT year-on-year change?

Over the past year, CNSP TTM earnings before interest & taxes has changed by +$1.56 M (+8.38%)